-
1 Comment
Second Sight Medical Products, Inc is currently in a long term uptrend where the price is trading 0.2% above its 200 day moving average.
From a valuation standpoint, the stock is 87.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 167.4.
Second Sight Medical Products, Inc's total revenue sank by 100.0% to $0 since the same quarter in the previous year.
Its net income has increased by 83.6% to $-1M since the same quarter in the previous year.
Finally, its free cash flow grew by 80.6% to $-1M since the same quarter in the previous year.
Based on the above factors, Second Sight Medical Products, Inc gets an overall score of 4/5.
CurrencyCode | USD |
---|---|
ISIN | US81362J2096 |
Industry | Health Care Equipment & Supplies |
Sector | Healthcare |
Exchange | NASDAQ |
Beta | 2.56 |
---|---|
Market Cap | 54M |
PE Ratio | None |
Target Price | 2.5 |
Dividend Yield | 0.0% |
As of August 30, 2022, Second Sight Medical Products, Inc. was acquired by Nano Precision Medical, Inc., in a reverse merger transaction. Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for EYES using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025